Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Read the full story on TechCrunch
Source: TechCrunch
Databases have traditionally been designed either for analytical data or for operational data. But database engine…
Jio plans to use most of its IPO proceeds to repay debt as it expands beyond…
Langley’s comments come amid mounting scrutiny of Flock from privacy advocates, including the ACLU, and members…
